New FDA Supply Chain Program Aims To Prevent Device Shortages
The new program will be the focus of the agency’s June workshop
Executive Summary
The US Food and Drug Administration is building a new Resilient Supply Chain Program, which aims to bolster the nation’s supply of essential medical devices and prevent future shortages.